GlassScriptPhysician profile
Henry C Warren
NPI 1447397484
$7,129.56
in general payments reported to CMS, 2019-2025
8 companies · $53.03 in 2025
The $53.03 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.84 · 2020: $57.66 · 2022: $5,815 · 2023: $38.46 · 2024: $1,149 · 2025: $53.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $960 · Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $960.00 |
| Food and Beverage | $280.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $5,814.65 | 2022 | |
| Convatec INC. | $960.00 | 2024 | |
| Medtronic, INC. | $122.40 | 2024 | Venaseal, Abre |
| Arthrosurface Incorporated | $87.89 | 2020-2025 | Toe Motiontm, Arthrosurface Bone Screw, Hemicap |
| Paratek Pharmaceuticals, INC. | $61.26 | 2023-2025 | Nuzyra |
| Depuy Synthes Sales INC. | $43.07 | 2024 | Motoband |
| Stryker Corporation | $23.45 | 2024 | Augment Injectable |
| Tactile Systems Technology INC | $16.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.